University of Pennsylvania

Insomnia Cookies Unveils Filled Chocolate Chunk Cookie in Honor of National Cookie Day

Wednesday, December 1, 2021 - 3:00pm

PHILADELPHIA, Dec. 1, 2021 /PRNewswire/ -- Insomnia Cookies announced today it will roll out its most mouthwatering cookie to date, a Filled Chocolate Chunk Cookie, just in time for National Cookie Day on December 4th.

Key Points: 
  • PHILADELPHIA, Dec. 1, 2021 /PRNewswire/ -- Insomnia Cookies announced today it will roll out its most mouthwatering cookie to date, a Filled Chocolate Chunk Cookie, just in time for National Cookie Day on December 4th.
  • A tantalizing take on the classic Chocolate Chunk, this thirst-trap of a cookie is stuffed to the brim with Insomnia's very-own rich, creamy Chocolate Cookie Butter and loaded with its iconic chocolate chunks.
  • "There's truly no better moment than National Cookie Day to share our latest creation with our community of Insomniacs."
  • Today with more than 200 locations nationwide, Insomnia Cookies offers a wide variety of delicious cookies and sweet treats in-store, for local delivery, and nationwide shipping.

AnaptysBio Announces Appointment of Daniel Faga to Board of Directors

Monday, November 29, 2021 - 9:05pm

SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced the appointment of Mr. Daniel Faga to the companys Board of Directors.

Key Points: 
  • SAN DIEGO, Nov. 29, 2021 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on emerging immune control mechanisms applicable to inflammation and immuno-oncology indications, today announced the appointment of Mr. Daniel Faga to the companys Board of Directors.
  • His unique strategic vision is an exciting addition to our Board of Directors and we look forward to having Dans perspective as AnaptysBio continues to advance multiple wholly-owned clinical and preclinical first-in-class therapeutic antibody programs.
  • Mr. Faga commented, AnaptysBio has an impressive track-record of innovating novel therapeutics and is financially well-positioned to drive potentially transformative medicines over the next several years.
  • AnaptysBio is a clinical-stage biotechnology company developing first-in-class antibody product candidates focused on unmet medical needs in inflammation.

Sustainable, People-centered Solutions for Affordable Housing to Take Center Stage at Eighth Asia-Pacific Housing Forum

Wednesday, November 24, 2021 - 11:00pm

"We must center our actions on the needs of the people to truly build in a greener, safer, more resilient way."

Key Points: 
  • "We must center our actions on the needs of the people to truly build in a greener, safer, more resilient way."
  • The forum's four tracks are Build resilient cities and communities; Innovative housing solutions and technologies; Advance sustainability in the housing sector; and Finance affordable housing.
  • The track on innovative housing solutions and technologies explores the various ways we can achieve affordable housing through innovation and technology.
  • The last track --finance affordable housing -- will focus on the financing instruments of different actors in both public and private sectors that fund affordable housing.

Blockchain-Based Antifragile Fund, BoCG Ventures, Announces Board Leadership Appointment of Richard Walden, JD

Wednesday, November 24, 2021 - 3:00pm

Walden is one the most trusted voices and brands for disaster aid relief, international development, and global public health legislation.

Key Points: 
  • Walden is one the most trusted voices and brands for disaster aid relief, international development, and global public health legislation.
  • "The addition of Richard will accelerate our efforts to become a market leader in finding and funding innovative portfolio companies.
  • - Lyon Kassab, Managing Partner
    As a BoCG Ventures advisor, Richard will oversee the social impact of our venture portfolios from a philanthropic lens.
  • About BoCG Ventures: BoCG Ventures' mission is to create market leading, antifragile brands.

Aflac Receives 2021 CSO50 Award From IDG's CSO Magazine

Tuesday, November 23, 2021 - 1:07pm

COLUMBUS, Ga., Nov. 23, 2021 /PRNewswire/ --Aflac, a leading provider of supplemental insurance in the U.S., announced that it has beenrecognized by IDG's CSO magazine as a recipient of the 2021 CSO50 Award.

Key Points: 
  • COLUMBUS, Ga., Nov. 23, 2021 /PRNewswire/ --Aflac, a leading provider of supplemental insurance in the U.S., announced that it has beenrecognized by IDG's CSO magazine as a recipient of the 2021 CSO50 Award.
  • In 2020, Aflac's Information Governance program modernized the organization's eDiscovery process, introducing new leading-practice services and capabilities to stakeholders.
  • "Our annual CSO50 Awards recognize security teams that bring innovation and thought leadership to solving for the many risks their organizations continue to face.
  • The 2021 awards will be presented at the CSO50 Conference + Awards held Nov. 16-18.

DWS Municipal Income Trust and DWS Strategic Municipal Income Trust Announce Addition of New Trustees

Monday, November 22, 2021 - 10:05pm

DWS Municipal Income Trust (NYSE: KTF) and DWS Strategic Municipal Income Trust (NYSE: KSM) (each, a Fund and collectively, the Funds) announced that Chad D. Perry and Catherine Schrand were each appointed as Class II Trustees of each Fund effective November 18, 2021.

Key Points: 
  • DWS Municipal Income Trust (NYSE: KTF) and DWS Strategic Municipal Income Trust (NYSE: KSM) (each, a Fund and collectively, the Funds) announced that Chad D. Perry and Catherine Schrand were each appointed as Class II Trustees of each Fund effective November 18, 2021.
  • Mr. Perry is Executive Vice President, General Counsel and Secretary, Tanger Factory Outlet Centers, Inc. (since 2011).
  • DWS Municipal Income Trust.
  • DWS Strategic Municipal Income Trust.

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium Highlighting Value of Genetic Testing in Breast Cancer Risk Assessment and Treatment

Monday, November 22, 2021 - 12:05pm

SALT LAKE CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two upcoming poster presentations at the 2021 San Antonio Breast Cancer Symposium (SABCS) that showcase the importance of genetic testing and precision medicine as integral components of both breast cancer treatment recommendations and risk assessment.

Key Points: 
  • SALT LAKE CITY, Nov. 22, 2021 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two upcoming poster presentations at the 2021 San Antonio Breast Cancer Symposium (SABCS) that showcase the importance of genetic testing and precision medicine as integral components of both breast cancer treatment recommendations and risk assessment.
  • These studies demonstrate our ongoing commitment to excellence in scientific research and the rapid translation of this research into clinical care, said Nicole Lambert, president, Myriad Genetics.
  • Follow Myriad on Twitter via @myriadgenetics and keep up to date with SABCS meeting news and updates by using the #SACBS21 hashtag.
  • Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and wellbeing for all, empowering individuals with vital genetic insights and enabling healthcare providers to better detect, treat and prevent disease.

BioSig to Participate in the The Benchmark Company 10th Annual Discovery Conference

Wednesday, November 17, 2021 - 2:45pm

Westport, CT, Nov. 17, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would participate in The Benchmark Company 10th Annual Discovery One on One Investor Conference (Virtual) on Thursday, December 2, 2021.

Key Points: 
  • Westport, CT, Nov. 17, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that it would participate in The Benchmark Company 10th Annual Discovery One on One Investor Conference (Virtual) on Thursday, December 2, 2021.
  • The Company is in a focused commercial launch of the PURE EP System in the Northeast , Texas , and Florida.
  • For parties interested in scheduling a one-on-one meeting with BioSig management, please contact the conference coordinators at: events@benchmarkcompany.com
    The Annual Benchmark Company Discovery Conference is hosted by The Benchmark Company, a boutique investment banking firm headquartered in New York, with regional offices across the country.
  • The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Cellares Appoints Ezekiel Emanuel to Board of Advisors

Tuesday, November 16, 2021 - 2:00pm

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 /PRNewswire/ -- Cellares Corporation , a life sciences technology company pioneering a revolutionary automated approach to cell therapy manufacturing, today announced the appointment of Ezekiel J. Emanuel, MD, PhD, to its Board of Advisors.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 /PRNewswire/ -- Cellares Corporation , a life sciences technology company pioneering a revolutionary automated approach to cell therapy manufacturing, today announced the appointment of Ezekiel J. Emanuel, MD, PhD, to its Board of Advisors.
  • Dr. Emanuel is a leading voice on public health issues, especially overcoming barriers that prevent patients from getting the care they need.
  • His guidance will be key as Cellares advances the Cell Shuttle, its end-to-end solution for scalable cell therapy manufacturing.
  • Advances in cell therapy, while life savings, are no different: they have consistently meant higher costs," said Emanuel.

ETS Establishes Legal Education Advisory Council to Expand and Create New Pathways in Legal Education

Monday, November 15, 2021 - 3:00pm

As the pathway from considering law school attendance to obtaining legal employment continues to encounter demands for innovation, legal education and thus ETS bears a heavy responsibility to reevaluate how law school aspirants, students and graduates are recruited, prepared, assessed and licensed.

Key Points: 
  • As the pathway from considering law school attendance to obtaining legal employment continues to encounter demands for innovation, legal education and thus ETS bears a heavy responsibility to reevaluate how law school aspirants, students and graduates are recruited, prepared, assessed and licensed.
  • The GRE test has brought an innovative approach to law school admissions that has enriched law school communities and has the potential to improve diversity access for years to come.
  • The members of LEAC will play a critical role in helping shape the future of legal education.
  • These activities include recruitment to law school, law school admissions, legal education, preparation of law students and graduates to practice law, and the licensure and employment of law school graduates.